Logo

American Heart Association

  30
  0


Final ID: MP174

Association Between Renal Artery Calcification and Renal Functional Outcomes After Revascularization According to CKD Stage in Renovascular Hypertension

Abstract Body (Do not enter title and authors here): Background: Calcification is a well-established prognostic marker for coronary artery disease. However, its implications for renal artery stenosis are not well understood, particularly in patients with renovascular hypertension and impaired renal function undergoing revascularization.

Objective: To investigate the impact of CKD stage and renal artery calcification assessed by intravascular ultrasound (IVUS) on renal functional outcomes after the revascularization in patients with renovascular hypertension.

Methods: We conducted a retrospective analysis of patients with renovascular hypertension due to unilateral renal artery stenosis. All procedures were performed stent implantation under the guidance of IVUS. Plaque burden, presence of calcification, calcium arc, and stent area were assessed by IVUS. Patients were stratified into two groups based on their pre-procedural estimated glomerular filtration rate (eGFR): high-stage CKD (HS-CKD; eGFR ≧45 mL/min/1.73 m2) and low-stage CKD (LS-CKD; eGFR <45 mL/min/1.73 m2). Renal functional outcome was measured using delta eGFR, calculated as the difference between baseline and 1-year post-procedural eGFR. Associations between IVUS findings and delta eGFR were assessed in both the HS-CKD and LS-CKD groups.

Results: A total of 33 patients (63.6% male, mean age 74.6 ± 9.1 years) were included. The follow-up duration was similar between the HS-CKD (n=13) and LS-CKD (n=20) groups (366 [267 to 381] vs. 356 [255 to 384] days, p=0.61). There was no significant difference in IVUS-derived vessel area, percent plaque area, and minimum stent area between the two groups. Renal artery calcification on IVUS was detected in 46.1% of the HS-CKD group and 65.0% of the LS-CKD group (p=0.28). In the HS-CKD group, the delta eGFR did not differ significantly between patients with and without calcification (−2 [−13 to 4] vs. 8 [−4 to 11.5] mL/min/1.73 m2, p=0.25). However, in the LS-CKD group, patients without calcification had a significantly lower delta eGFR than those with calcification (−4 [−6 to 1.5] vs. −1 [−2 to 8] mL/min/1.73 m2, p=0.04). No significant association was observed between calcium arc and delta eGFR in either group.

Conclusion: In patients with renovascular hypertension due to unilateral renal artery stenosis, the presence of renal artery calcification has a potential association with renal function after revascularization, regardless of the degree of calcification, especially in those with lower stage CKD.
  • Kawai, Kenji  ( Hyogo Medical University , Nishinomiya , Japan )
  • Mine, Takanao  ( Hyogo Medical University , Nishinomiya , Japan )
  • Hoshina, Rin  ( Hyogo Medical University , Nishinomiya , Japan )
  • Akahori, Hirokuni  ( Hyogo Medical University , Nishinomiya , Japan )
  • Miki, Kojiro  ( Hyogo Medical University , Nishinomiya , Japan )
  • Yoshihara, Nagataka  ( Hyogo Medical University , Nishinomiya , Japan )
  • Tanaka, Hirokazu  ( Hyogo Medical University , Nishinomiya , Japan )
  • Ishihara, Masaharu  ( Hyogo Medical University , Nishinomiya , Japan )
  • Author Disclosures:
    Kenji Kawai: DO NOT have relevant financial relationships | Takanao Mine: DO have relevant financial relationships ; Speaker:DAIICHI SANKYO COMPANY, LIMITED :Active (exists now) ; Advisor:Kaneka Corporation:Active (exists now) ; Advisor:Fukuda Denshi Co., Ltd.:Active (exists now) ; Advisor:Nihon Kohden Corporation:Active (exists now) ; Speaker:Alnylam Japan, Inc.:Active (exists now) ; Other (please indicate in the box next to the company name):ABBOTT JAPAN Co., LTD:Active (exists now) ; Other (please indicate in the box next to the company name):Medtronic Japan Co., Ltd:Active (exists now) ; Speaker:Nippon Boehringer Ingelheim Co., Ltd.:Past (completed) | Rin Hoshina: DO NOT have relevant financial relationships | Hirokuni Akahori: No Answer | Kojiro Miki: DO NOT have relevant financial relationships | Nagataka Yoshihara: DO NOT have relevant financial relationships | HIROKAZU TANAKA: No Answer | Masaharu Ishihara: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Silent Drivers: Cardiovascular Risk in Chronic Kidney Disease

Saturday, 11/08/2025 , 10:45AM - 12:00PM

Moderated Digital Poster Session

More abstracts on this topic:
18F-NaF and 18F-FDG and calcification predict the development of abdominal aortic aneurysms and is attenuated by drug therapy

Nakahara Takehiro, Miyazawa Raita, Iwabuchi Yu, Tonda Kai, Narula Nupoor, Strauss Harry, Narula Jagat, Jinzaki Masahiro

AI-Measured Thoracic Ascending Aortic Calcification in CAC Scans Predicts Cardiovascular Events: An AI-CVD study in the FHS Offspring Cohort

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Wasserthal Jakob, Wong Nathan, Benjamin Emelia, Levy Daniel

More abstracts from these authors:
Impact of lipoprotein(a) levels on subsequent cardiovascular events after endovascular therapy for femoropopliteal lesion

Hoshina Rin, Akahori Hirokuni, Yoshihara Nagataka, Miki Kojiro, Kawai Kenji, Ishihara Masaharu

Intraoperative indicators depending on QRS morphology are required to narrow QRS width during CRT implantation

Mine Takanao, Terao Soichiro, Sugitani Miho, Kogame Takehiro, Ishihara Masaharu

You have to be authorized to contact abstract author. Please, Login
Not Available